These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 37291944)
1. Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma. Mansoor A; Akhter A; Shabani-Rad MT; Deschenes J; Yilmaz A; Trpkov K; Stewart D Hematol Oncol; 2023 Dec; 41(5):828-837. PubMed ID: 37291944 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320 [TBL] [Abstract][Full Text] [Related]
3. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions. Meng Y; Quan L; Liu A Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex. Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351 [TBL] [Abstract][Full Text] [Related]
5. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies. Twa DDW; Mottok A; Savage KJ; Steidl C Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361 [TBL] [Abstract][Full Text] [Related]
6. Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma. Robertus JL; Harms G; Blokzijl T; Booman M; de Jong D; van Imhoff G; Rosati S; Schuuring E; Kluin P; van den Berg A Mod Pathol; 2009 Apr; 22(4):547-55. PubMed ID: 19287466 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients. Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978 [TBL] [Abstract][Full Text] [Related]
8. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray. Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857 [TBL] [Abstract][Full Text] [Related]
9. HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma. Jia YJ; Liu ZB; Wang WG; Sun CB; Wei P; Yang YL; You MJ; Yu BH; Li XQ; Zhou XY Leukemia; 2018 Mar; 32(3):703-711. PubMed ID: 29135973 [TBL] [Abstract][Full Text] [Related]
10. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients. Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897 [TBL] [Abstract][Full Text] [Related]
11. [Significance of microRNA-146b-5p in diffuse large B-cell lymphoma and its relationship with risk assessment]. Cao QW; Li HY; Yao XX; Wang JF Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1010-4. PubMed ID: 23363792 [TBL] [Abstract][Full Text] [Related]
12. Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma. Zhang S; Wang L; Cheng L Mol Carcinog; 2019 Oct; 58(10):1846-1854. PubMed ID: 31237044 [TBL] [Abstract][Full Text] [Related]
13. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis. Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression. Ting CY; Tan SY; Gan GG; Zain SM; Pung YF; Ong DB; Bee PC Int J Lab Hematol; 2022 Oct; 44(5):907-917. PubMed ID: 35830966 [TBL] [Abstract][Full Text] [Related]
15. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone. Wu PY; Zhang XD; Zhu J; Guo XY; Wang JF Hum Pathol; 2014 Aug; 45(8):1664-73. PubMed ID: 24931464 [TBL] [Abstract][Full Text] [Related]
16. A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors. Sromek M; Rymkiewicz G; Paziewska A; Szafron LM; Kulecka M; Zajdel M; Kulinczak M; Dabrowska M; Balabas A; Bystydzienski Z; Chechlinska M; Siwicki JK Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572608 [TBL] [Abstract][Full Text] [Related]
17. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. Deng L; Xu-Monette ZY; Loghavi S; Manyam GC; Xia Y; Visco C; Huh J; Zhang L; Zhai Q; Wang Y; Qiu L; Dybkær K; Chiu A; Perry AM; Zhang S; Tzankov A; Rao H; Abramson J; Sohani AR; Xu M; Hsi ED; Zhu J; Ponzoni M; Wang S; Li L; Zhang M; Ferreri AJ; Parsons BM; Li Y; Piris MA; Medeiros LJ; Young KH Leukemia; 2016 Feb; 30(2):361-72. PubMed ID: 26308769 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF- Li C; Huang L; Wen Y; Yi M; Gao M Genet Res (Camb); 2022; 2022():3222253. PubMed ID: 36619898 [TBL] [Abstract][Full Text] [Related]
19. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469 [TBL] [Abstract][Full Text] [Related]
20. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis. Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]